FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to compounds of formula
wherein A means N or CH; and n is equal to 0 or 1; or their pharmaceutically acceptable salts for preventing or treating intestinal diseases caused by a bacterium specified in Clostridium difficile, Clostridium perfringens or Staphylococcus aureus.
EFFECT: present invention possesses a high activity on the agents of intestinal infections, reduces a toxin load, spore production inducing thereby the minimum effect on the flora produced in the intestine.
9 cl, 1 dwg, 3 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYBRID ANTIBACTERIAL AGENTS OXAZOLIDINONE-QUINOLONE INTENDED FOR PARENTERAL ADMINISTRATION FOR TREATMENT OR PREVENTION OF BACTERIAL DISEASES | 2014 |
|
RU2702364C2 |
| ANTIBACTERIAL COMPOUNDS | 2009 |
|
RU2525915C2 |
| COMPOUNDS FOR TREATING CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES | 2011 |
|
RU2575477C2 |
| PYRIMIDINE GYRASE AND TOPOISOMERASE IV INHIBITORS | 2012 |
|
RU2609259C2 |
| SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[6-FLUORO-5-[2-(1-HYDROXY-1-METHYL-ETHYL) PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL] UREA | 2012 |
|
RU2625305C2 |
| NOVEL ANTIBACTERIAL MEDICATIONS FOR TREATMENT OF GRAM-POSITIVE INFECTIONS | 2009 |
|
RU2512396C2 |
| KIBDELOS PORANGIUM EXTRACTS AS ANTIBACTERIAL AGENTS | 2010 |
|
RU2572621C2 |
| HYDROXYALKYLTHIADIAZOLE DERIVATIVES | 2016 |
|
RU2737892C1 |
| 5-HYDROXYMETHYLOXAZOLIDIN-2-ONE DERIVATIVES | 2007 |
|
RU2453546C2 |
| OXAZOLIDINE ANTIBIOTICS | 2009 |
|
RU2516701C2 |
